Overview
- 6 inspections across 6 sites are on record.
- 9 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-03-06.
At a glance
Inspections
6
Sites
6
Observations
9
Career since
Mar 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| NATCO Pharma Limited | 6 Mar 2020 | Human Drugs | On file |
| Strides Pharma Science Limited | 24 Jan 2020 | Human Drugs | |
| EUGIA Pharma Specialities Limited | 8 Jun 2018 | Human Drugs | |
| Graviti Pharmaceuticals Private Limited | 13 Apr 2018 | Human Drugs | On file |
| Zydus Lifesciences Limited | 16 Feb 2017 | Human Drugs |
Sites inspected
NATCO Pharma LimitedRangareddy, India1 insp.
Strides Pharma Science LimitedChengalpattu, India1 insp.
EUGIA Pharma Specialities LimitedMedchal-Malkajgiri District, India1 insp.
Graviti Pharmaceuticals Private LimitedHyderabad, India1 insp.
Zydus Lifesciences LimitedAhmedabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Bijoy Panicker1 shared
Tamil Arasu1 shared
Angela E Glenn1 shared
Marcus A Ray1 shared
Susanna E Ford1 shared
Seneca D Toms1 shared
Jason K Morgan1 shared
Erika V Butler1 shared
Full investigator report
Get the verbatim findings behind Zhaoyang Meng's 9 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site